Inactive

On behalf of the National Institute of Neurological Disorders and Stroke (NINDS), the Office of Acquisitions Contracts Management Branch Red, NINDS Section of the National Institute on Drug Abuse (NID... On behalf of the National Institute of Neurological Disorders and Stroke (NINDS), the Office of Acquisitions Contracts Management Branch Red, NINDS Section of the National Institute on Drug Abuse (NIDA), intends to solicit on a sole-source basis by a request for quotation to Li-COR Biosciences to acquire a 3350-02 Odyssey M (Chemi/Fluor) - Data Integrity Bundle Plus (Imager) on or around September 1, 2023 with an award issued on or around September 25, 2023. The purpose of this acquisition is to acquire a 3350-02 Odyssey M (Chemi/Fluor) - Data Integrity Bundle Plus (Imager) to perform several assays in a single unit and will expand the repertoire of biochemical and molecular biology techniques our group will be able to perform. The Imager shall be provided by an Original Equipment Manufacturer (OEM)-Authorized Service Provider of the 3350-02 Odyssey M (Chemi/Fluor) - Data Integrity Bundle Plus.